Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 20/20 | 0.73 |
| ▸ | HDAC3 | O15379 | 16/20 | 0.73 |
| ▸ | HDAC2 | Q92769 | 16/20 | 0.73 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.73 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.73 |
| ▸ | NCOR2 | Q9Y618 | 12/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.67 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.67 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.67 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.67 |
| ▸ | TET3 | O43151 | 1/20 | 0.67 |
| ▸ | BRD4 | O60885 | 1/20 | 0.67 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.67 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.67 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.67 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164803 | 1.00 | HDAC1 (0.73) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL3261129 | 1.00 | HDAC1 (0.73) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL28780671 | 0.87 | HDAC1 (0.68) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| Hydrochloric Acid SCHEMBL27745415 | 0.86 | HDAC1 (0.67) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL19806242 | 0.85 | HDAC1 (0.70) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL4380126 | 0.84 | HDAC1 (1.00) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL4380122 | 0.84 | HDAC1 (1.00) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL29454794 | 0.84 | HDAC1 (1.00) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL28634425 | 0.84 | HDAC1 (0.72) | HDAC1HDAC3HDAC2HDAC8HDAC4 | |
| SCHEMBL30255503 | 0.83 | HDAC1 (0.83) | HDAC1HDAC3HDAC2HDAC8HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2968340-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | Intellikine, LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2855483-A1 | PYRROLOPYRROLIDINONE COMPOUNDS | Novartis AG (CH) | 2015-04-08 | — | — | EP | disclosed |
| EP-2807164-A1 | IMIDAZOPYRROLIDINONE COMPOUNDS | Novartis AG (CH) | 2014-12-03 | — | — | EP | disclosed |
| EP-2782571-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Intellikine, LLC (US) | 2014-10-01 | — | — | EP | disclosed |
| WO-2014151147-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| EP-2776441-A1 | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | Intellikine, LLC (US) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776837-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | Intellikine, LLC (US) | 2014-09-17 | — | — | EP | disclosed |
| EP-2705181-A1 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Intellikine, LLC (US) | 2014-03-12 | — | — | EP | disclosed |
| EP-2678016-A2 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | Intellikine, LLC (US) | 2014-01-01 | — | — | EP | disclosed |
| WO-2013175417-A1 | PYRROLOPYRROLIDINONE COMPOUNDS | NOVARTIS AG (CH) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013111105-A1 | IMIDAZOPYRROLIDINONE COMPOUNDS | NOVARTIS AG (CH) | 2013-08-01 | — | — | WO | disclosed |
| WO-2013078441-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | INTELLIKINE, LLC (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013070976-A1 | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | INTELLIKINE, LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013071264-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| WO-2012154608-A1 | REACTIVE MTOR AND PI3 KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-11-15 | — | — | WO | disclosed |
| WO-2012154610-A1 | REACTIVE PI3K KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-11-15 | — | — | WO | disclosed |
| WO-2012151562-A1 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012148540-A1 | COMBINATION OF KANASE INHIBITORS AND USES THREOF | INTELLIKINE, LLC (US) | 2012-11-01 | — | — | WO | disclosed |
| EP-2516009-A1 | SUBSTITUTED ISOQUINOLINONES AND QUINAZOLINONES | Novartis AG (CH) | 2012-10-31 | — | — | EP | disclosed |
| WO-2012116237-A2 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-08-30 | — | — | WO | disclosed |